Skip to main content
. 2004 Sep 15;10(18):2661–2665. doi: 10.3748/wjg.v10.i18.2661

Figure 2.

Figure 2

Mean TGF-β1 plasma concentrations before and dur-ing lamivudine therapy as well as 24 wk after its completion (wk 72) in respect to the final effect of the treatment. Statistical significance in comparison to normal values are indicated with asterisks and between groups with arrows.